CC BY 4.0 · Eur J Dent 2022; 16(01): 145-152
DOI: 10.1055/s-0041-1731928
Original Article

Periodontitis and Helicobacter pylori Infection: Eradication and Periodontal Therapy Combination

Athanasios Tsimpiris
1   Department of Medicine, Democritus University of Thrace, Alexandroupolis, Greece
2   Dental Sector, 424 General Military Training Hospital, Thessaloniki, Greece
,
2   Dental Sector, 424 General Military Training Hospital, Thessaloniki, Greece
3   Department of Preventive Dentistry, Periodontology and Implant Biology, Dental School, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece
,
Ioannis Tsolianos
4   Dental School, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece
,
Ioannis Moschos
5   Department of Nursing, International Hellenic University, Thessaloniki, Greece
,
Dimitrios G. Goulis
6   Unit of Reproductive Endocrinology, First Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece
,
Georgios Kouklakis
7   A' Department of Pathology, Department of Medicine, Democritus University of Thrace, Alexandroupolis, Greece
› Author Affiliations

Abstract

Objectives This study was aimed to assess (1) the prevalence of salivary and gastric Helicobacter pylori (HP) infection in patients with and without periodontitis, (2) the prevalence of HP infection in patients with periodontitis according to its clinical classification, (3) the effect of periodontitis treatment in patients with or without gastric HP infection, and (4) if gastric HP eradication in combination with periodontitis treatment influences periodontitis clinical outcome.

Materials and Methods Thirty-three adults with periodontitis treated by quadrant scaling and root planning (QSRP). The simplified plaque index (PI), bleeding on probing index (BOP), probing pocket depth (PPD), and clinical attachment level (CAL) were assessed pretreatment and 3 months of posttreatment. The patients were tested for oral and gastric HP. Gastric HP (+) patients received eradication therapy. A control group of 32 periodontically healthy volunteers was tested for oral and gastric HP. Saliva samples were evaluated by real-time polymerase chain reaction (rtPCR); gastric HP was detected by urea breath test (UBT).

Statistical Analysis Normality of variables assessed by the Kolmogorov–Smirnov test, while the differences of pre- and post-treatment were analyzed by paired samples t-test. Differences between subgroups were compared by a Student’s t-test or a Mann–Whitney U-test. Comparisons of nominal variables were made by Pearson’s Chi-square test.

Results No saliva samples were positive for HP. Gastric HP was detected in six patients with periodontitis and seven controls (p > 0.05). HP infection affected patients with higher disease stages and grades. All HP (+) patients underwent successful eradication treatment. All clinical periodontitis indices improved following QSRP. HP (+) patients who received QSRP as adjunctive to eradication treatment showed improvement in BOP (p < 0.001), PI (p < 0.013), and CAL (p < 0.004) compared with HP (−) patients who received QSRP alone.

Conclusion Periodontitis was not associated with gastric HP infection. Saliva was not a gastric HP supply reservoir. Gastric HP infection was associated with advanced stages and grades of periodontitis. Although all periodontal clinical markers improved after QSRP, BOP, PI, and CAL, they were further improved when combined with eradication treatment. Periodontal evaluation and treatment combined with HP eradication are recommended in patients with HP gastric infection.



Publication History

Article published online:
01 October 2021

© 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).

Thieme Medical and Scientific Publishers Private Ltd
A-12, Second Floor, Sector -2, NOIDA -201301, India

 
  • References

  • 1 Frencken JE, Sharma P, Stenhouse L, Green D, Laverty D, Dietrich T. Global epidemiology of dental caries and severe periodontitis - a comprehensive review. J Clin Periodontol 2017; 44 (Suppl. 18) S94-S105
  • 2 Tonetti MS, Jepsen S, Jin L, Otomo-Corgel J. Impact of the global burden of periodontal diseases on health, nutrition and wellbeing of mankind: a call for global action. J Clin Periodontol 2017; 44 (05) 456-462
  • 3 Nair S, Faizuddin M, Dharmapalan J. Role of autoimmune responses in periodontal disease. Autoimmune Dis 2014; 2014: 596824
  • 4 Cekici A, Kantarci A, Hasturk H. Van Dyke TE. Inflammatory and immune pathways in the pathogenesis of periodontal disease. Periodontol 2000 2014; 64 (01) 57-80
  • 5 Socransky SS, Haffajee AD. Dental biofilms: difficult therapeutic targets. Periodontol 2000 2002; 28: 12-55
  • 6 Bui FQ, Almeida-da-Silva CL, Huynh B. et al. Association between periodontal pathogens and systemic disease. Biomed J 2019; 42 (01) 27-35
  • 7 Ansari S, Yamaoka Y. Survival of Helicobacter pylori in gastric acidic territory. Helicobacter 2017; 22 (04) e12386
  • 8 Zamani M, Ebrahimtabar F, Zamani V. et al. Systematic review with meta-analysis: the worldwide prevalence of Helicobacter pylori infection. Aliment Pharmacol Ther 2018; 47 (07) 868-876
  • 9 Watari J, Chen N, Amenta PS. et al. Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development. World J Gastroenterol 2014; 20 (18) 5461-5473
  • 10 Bravo D, Hoare A, Soto C, Valenzuela MA, Quest AF. Helicobacter pylori in human health and disease: Mechanisms for local gastric and systemic effects. World J Gastroenterol 2018; 24 (28) 3071-3089
  • 11 Taş DA, Yakar T, Sakalli H, Serin E. Impact of Helicobacter pylori on the clinical course of recurrent aphthous stomatitis. J Oral Pathol Med 2013; 42 (01) 89-94
  • 12 Adler I, Denninghoff VC, Alvarez MI, Avagnina A, Yoshida R, Elsner B. Helicobacter pylori associated with glossitis and halitosis. Helicobacter 2005; 10 (04) 312-317
  • 13 Attia EA, Abdel Fattah NS, Abdella HM. Upper gastrointestinal findings and detection of Helicobacter pylori in patients with oral lichen planus. Clin Exp Dermatol 2010; 35 (04) 355-360
  • 14 Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG clinical guideline: treatment of Helicobacter pylori infection. Am J Gastroenterol 2017; 112 (02) 212-239
  • 15 Anand PS, Kamath KP, Anil S. Role of dental plaque, saliva and periodontal disease in Helicobacter pylori infection. World J Gastroenterol 2014; 20 (19) 5639-5653
  • 16 Dye BA, Kruszon-Moran D, McQuillan G. The relationship between periodontal disease attributes and Helicobacter pylori infection among adults in the United States. Am J Public Health 2002; 92 (11) 1809-1815
  • 17 Papapanou PN, Sanz M, Buduneli N. et al. Periodontitis: consensus report of workgroup 2 of the 2017 world workshop on the classification of periodontal and peri-implant diseases and conditions. J Periodontol 2018; 89 (Suppl. 01) S173-S182
  • 18 McHugh ML. Interrater reliability: the kappa statistic. Biochem Med (Zagreb) 2012; 22 (03) 276-282
  • 19 Malfertheiner P, Megraud F, O’Morain CA. et al. European Helicobacter and Microbiota Study Group and Consensus panel. Management of Helicobacter pylori infection-the Maastricht V/Florence consensus report. Gut 2017; 66 (01) 6-30
  • 20 Cohen J. Statistical Power Analysis for the Behavioral Sciences. Revised ed. New York, NY: Academic Press 2013: 14-17
  • 21 Kignel S, de Almeida Pina F, André EA, Alves Mayer MP, Birman EG. Occurrence of Helicobacter pylori in dental plaque and saliva of dyspeptic patients. Oral Dis 2005; 11 (01) 17-21
  • 22 Silva DG, Stevens RH, Macedo JMB. et al. Presence of Helicobacter pylori in supragingival dental plaque of individuals with periodontal disease and upper gastric diseases. Arch Oral Biol 2010; 55 (11) 896-901
  • 23 Hardo PG, Tugnait A, Hassan F. et al. Helicobacter pylori infection and dental care. Gut 1995; 37 (01) 44-46
  • 24 Silva Rossi-Aguiar VP, Navarro-Rodriguez T, Mattar R. et al. Oral cavity is not a reservoir for Helicobacter pylori in infected patients with functional dyspepsia. Oral Microbiol Immunol 2009; 24 (03) 255-259
  • 25 Asikainen S, Chen C, Slots J. Absence of Helicobacter pylori in subgingival samples determined by polymerase chain reaction. Oral Microbiol Immunol 1994; 9 (05) 318-320
  • 26 Goosen C, Theron J, Ntsala M. et al. Evaluation of a novel heminested PCR assay based on the phosphoglucosamine mutase gene for detection of Helicobacter pylori in saliva and dental plaque. J Clin Microbiol 2002; 40 (01) 205-209
  • 27 Valadan Tahbaz S, Yadegar A, Amirmozafari N, Yaghoobee S, Ehsani Ardakani MJ, Zojaji H. Occurrence of Helicobacter pylori and its major virulence genotypes in dental plaque samples of patients with chronic periodontitis in Iran. Gastroenterol Hepatol Bed Bench 2017; 10 (Suppl. 01) S70-S78
  • 28 Song Q, Lange T, Spahr A, Adler G, Bode G. Characteristic distribution pattern of Helicobacter pylori in dental plaque and saliva detected with nested PCR. J Med Microbiol 2000; 49 (04) 349-353
  • 29 Yee JK. Helicobacter pylori colonization of the oral cavity: a milestone discovery. World J Gastroenterol 2016; 22 (02) 641-648
  • 30 Okuda K, Kimizuka R, Katakura A, Nakagawa T, Ishihara K. Ecological and immunopathological implications of oral bacteria in Helicobacter pylori-infected disease. J Periodontol 2003; 74 (01) 123-128
  • 31 Czesnikiewicz-Guzik M, Bielanski W, Guzik TJ, Loster B, Konturek SJ. Helicobacter pylori in the oral cavity and its implications for gastric infection, periodontal health, immunology and dyspepsia. J Physiol Pharmacol 2005; 56 (Suppl. 06) 77-89
  • 32 Nisha KJ, Nandakumar K, Shenoy KT, Janam P. Periodontal disease and Helicobacter pylori infection: a community-based study using serology and rapid urease test. J Investig Clin Dent 2016; 7 (01) 37-45
  • 33 Al Asqah M, Al Hamoudi N, Anil S, Al Jebreen A, Al-Hamoudi WK. Is the presence of Helicobacter pylori in dental plaque of patients with chronic periodontitis a risk factor for gastric infection?. Can J Gastroenterol 2009; 23 (03) 177-179
  • 34 Engstrand L, Nguyen AM, Graham DY, el-Zaatari FA. Reverse transcription and polymerase chain reaction amplification of rRNA for detection of Helicobacter species. J Clin Microbiol 1992; 30 (09) 2295-2301
  • 35 Momtaz H, Souod N, Dabiri H, Sarshar M. Study of Helicobacter pylori genotype status in saliva, dental plaques, stool and gastric biopsy samples. World J Gastroenterol 2012; 18 (17) 2105-2111
  • 36 Kabir S. Detection of Helicobacter pylori DNA in feces and saliva by polymerase chain reaction: a review. Helicobacter 2004; 9 (02) 115-123
  • 37 Morales-Espinosa R, Fernandez-Presas A, Gonzalez-Valencia G. et al. Helicobacter pylori in the oral cavity is associated with gastroesophageal disease. Oral Microbiol Immunol 2009; 24 (06) 464-468
  • 38 Rahman L, Rahman A, Bakir A, Muhamadamin R, Khudhur P. DNA detection of Helicobacter pylori in saliva of patients with low salivary pH. Zanco J Med Sci 2020; 24: 283-290
  • 39 Ren Q, Yan X, Zhou Y, Li WX. Periodontal therapy as adjunctive treatment for gastric Helicobacter pylori infection. Cochrane Database Syst Rev 2016; 2: CD009477
  • 40 Bouziane A, Ahid S, Abouqal R, Ennibi O. Effect of periodontal therapy on prevention of gastric Helicobacter pylori recurrence: a systematic review and meta-analysis. J Clin Periodontol 2012; 39 (12) 1166-1173
  • 41 Zarić S, Bojić B, Janković Lj. et al. Periodontal therapy improves gastric Helicobacter pylori eradication. J Dent Res 2009; 88 (10) 946-950
  • 42 Zheng P, Zhou W. Relation between periodontitis and helicobacter pylori infection. Int J Clin Exp Med 2015; 8 (09) 16741-16744
  • 43 Zahedi L, Jafari E, Torabi Parizi M. et al. The association between oral hygiene and gastric pathology in patients with dyspepsia: a cross-sectional study in Southeast Iran. Middle East J Dig Dis 2017; 9 (01) 33-38
  • 44 Adachi K, Notsu T, Mishiro T, Yoshikawa H, Kinoshita Y. Influence of Helicobacter pylori infection on periodontitis. J Gastroenterol Hepatol 2019; 34 (01) 120-123
  • 45 Heitz-Mayfield LJ. Systemic antibiotics in periodontal therapy. Aust Dent J 2009; 54 (Suppl. 01) S96-S101
  • 46 Rôças IN, Siqueira Jr JF. Searching for Helicobacter pylori and Chlamydia pneumoniae in primary endodontic infections. Eur J Dent 2012; 6 (02) 158-162
  • 47 Ishihara K, Miura T, Ebihara Y, Hirayama T, Kamiya S, Okuda K. Shared antigenicity between Helicobacter pylori and periodontopathic Campylobacter rectus strains. FEMS Microbiol Lett 2001; 197 (01) 23-27
  • 48 Umeda M, Kobayashi H, Takeuchi Y. et al. High prevalence of Helicobacter pylori detected by PCR in the oral cavities of periodontitis patients. J Periodontol 2003; 74 (01) 129-134